Compare PEN & REG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PEN | REG |
|---|---|---|
| Founded | 2004 | 1963 |
| Country | United States | United States |
| Employees | N/A | 507 |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 14.2B |
| IPO Year | 2015 | N/A |
| Metric | PEN | REG |
|---|---|---|
| Price | $333.28 | $80.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 15 |
| Target Price | ★ $357.33 | $80.07 |
| AVG Volume (30 Days) | 548.7K | ★ 1.1M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 3.82% |
| EPS Growth | ★ 1155.56 | N/A |
| EPS | ★ 4.52 | N/A |
| Revenue | ★ $1,403,665,000.00 | N/A |
| Revenue This Year | $14.34 | $3.04 |
| Revenue Next Year | $13.71 | $4.52 |
| P/E Ratio | $73.42 | ★ $26.85 |
| Revenue Growth | ★ 17.50 | N/A |
| 52 Week Low | $221.26 | $66.86 |
| 52 Week High | $362.41 | $81.66 |
| Indicator | PEN | REG |
|---|---|---|
| Relative Strength Index (RSI) | 52.22 | 65.00 |
| Support Level | $326.58 | $69.52 |
| Resistance Level | $336.01 | N/A |
| Average True Range (ATR) | 2.27 | 1.17 |
| MACD | 0.43 | 0.22 |
| Stochastic Oscillator | 72.14 | 82.48 |
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 481 properties, which includes over 58 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.